Interestingly, despite the clear association between elevated CBX4 expression and aggressive HNSCC phenotypes, our survival analysis indicated no statistically significant impact of CBX4 expression levels on overall patient survival (p = 0.12, Figure 1D). Here, CBX4 is linked to head and neck squamous cell carcinoma.